Covered recipient · General Payments record
KATHRYN J DRINKARD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$572.66
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.90 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $132.47 | 5 |
| Lilly USA, LLC | $44.10 | 2 |
| PFIZER INC. | $34.11 | 1 |
| Acerta Pharma LLC | $32.84 | 1 |
| Novo Nordisk AS | $32.27 | 1 |
| GlaxoSmithKline, LLC. | $31.52 | 1 |
| ABBVIE INC. | $24.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.59 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103659944 | CMS |
| Astellas Pharma US Inc | $23.57 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139318512 | CMS |
| Astellas Pharma US Inc | $29.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139363875 | CMS |
| Astellas Pharma US Inc | $26.63 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139273628 | CMS |
| Astellas Pharma US Inc | $27.44 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139428604 | CMS |
| Astellas Pharma US Inc | $25.51 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139444936 | CMS |
| AstraZeneca Pharmaceuticals LP | $32.84 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104512074 | CMS |
| GlaxoSmithKline, LLC. | $31.52 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116370513 | CMS |
| Lilly USA, LLC | $21.91 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135101000 | CMS |
| Lilly USA, LLC | $22.19 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076817 | CMS |
| Novo Nordisk Inc | $32.27 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097507390 | CMS |
| PFIZER INC. | $34.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132103423 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.